Reva Medical, Inc.

Axonics Modulation Technologies, Inc.

Axonics, Inc.

Apex Medical Technologies, Inc.

Rutgers, the State University of New Jersey

Avery Dennison Corporation

Lrc Products Limited

Regent Medical Limited

Kimberly-clark Worldwide, Inc.

I-flow Corporation Inc.

Eric V Schmid

Dennis Lynn Schroeder

Andrew Morris

John Woock

Guangqiang Jiang

Joan Zeltinger

Steven C Howard

Donald K Brandom

Orlando M Padilla

Keith Allen Esser

Mark W McGlothlin

John Dang Nguyen

Craig L Bonsignore

Keith Weier

Joachim B Kohn

Stuart Karten

Durgadas Bolikal

Thomas R Jackson

Robert F Eisele

Daniel Moore

Joseph Anthony DiPari

Philip Simpson

Prabodh Mathur

Rinda Sama

Jeffrey T Sheriff

Joseph J Mallon

James E McGrath

Robert K Schultz

Andres Dandler

Guanqiang Jiang

John Hobson

James E Mcgrath

Brian P Watschke

David G Matsuura

Walter Dean Gillespie

Ronald Ugolick

Norman Curtis Yamamoto

Brandon McNary Felkins

Don K Brandom

Chia-Ee Alice Chou

Alice A DePaul

Guangqing Jiang

Orlanda Padilla

Aaron F Pesnell

John D Nguyen

Joe Dipari

Keith Esser

Stephen C Howard

Jiang Guangqiang

Mark W Mcglothlin

Methods and systems for obtaining and analyzing electromyography responses of electrodes of an implanted neurostimulation lead for use neurostimulation programming are provided herein. System setups for neural localization and/or programming include a clinician programmer coupleable with a temporary or permanent lead implantable in a patient and at least one pair of EMG sensing electrodes minimally invasively positioned on a skin surface or within the patient. The clinician programmer is configured to determine a plurality of recommended electrode configurations based on thresholds and EMG responses of the plurality of electrodes and rank the electrode configuration according to pre-determined criteria. The clinician programmer further includes graphical user interface on which the plurality of recommended electrode configurations are displayed for modification and/or selection by a clinician in programming an IPG or EPG coupled with the lead to apply a neurostimulation treatment according to the selected electrode configuration.

Methods for determining neurostimulation electrode configurations based on neural localization

The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead. A stimulation-induced EMG motor response is recorded with the integrated clinician programmer for each test stimulation on each electrode of the implantable lead via the at least one pair of EMG sensing electrodes so as to facilitate initial positioning of the implantable lead at a target stimulation region.

Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder

Systems and methods for providing a trial neurostimulation to a patient for assesssing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG patch adhered to a skin surface of a patient and connected to a lead extending through a percutaneous incision to a target tissue location. The EPG may be a modified version of the IPG used in the permanent system, the EPG may be smaller and/or lighter than the corresponding IPG device. The EPG and a lead extension may be sealed to allow improved patient mobility and reduced risk of infection. The EPG may be compatible with wireless systems used to control and monitor the IPG such that operation and control of the EPG is substantially the same in each system to allow seemless conversion to the permanently implanted system.

External pulse generator device and associated methods for trial nerve stimulation

Preferred embodiments relate to compositions of inherently radiopaque, biocompatible, bioresorbable polymeric particles and methods of using them for embolizing a body lumen.

Inherently radiopaque polymeric products for embolotherapy

A neurostimulation system having an external or an implantable pulse generator programmed to innervate a specific nerve or group of nerves in a patient through an electrode as a mode of treatment, having a patient remote that wirelessly communicates with the pulse generator to increase stimulation, decrease stimulation, and provide indications to a patient regarding the status of the neurostimulation system. The patient remote can allow for adjustment of stimulation power within a clinically effective range and for turning on and turning off the pulse generator. The patient remote and neurostimulation system can also store a stimulation level when the pulse generator is turned off and automatically restore the pulse generator to the stored stimulation level when the pulse generator is turned on.

Patient remote and associated methods of use with a nerve stimulation system

A clinician programmer may be coupled with an implantable temporary or permanent lead in a patient. Generally, the clinician programmer may comprise a portable housing, a signal/stimulation generator, and a graphical user interface. The housing has an external surface and encloses circuitry at least partially disposed within the housing. The signal/stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or for use with a keyboard, mouse, or the like.

Clinician programmer for use with an implantable neurostimulation lead

Patient remote

Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG patch adhered to a skin surface of a patient and connected to a lead extending through a percutaneous incision to a target tissue location. The EPG may be a modified version of the IPG used in the permanent system, the EPG may be smaller and/or lighter than the corresponding IPG device. The EPG and a lead extension may be sealed to allow improved patient mobility and reduced risk of infection. The EPG may be compatible with wireless systems used to control and monitor the IPG such that operation and control of the EPG is substantially the same in each system to allow seamless conversion to the permanently implanted system.

A multichannel clip device and methods of use that facilitate connection of multiple electrical components of a first device and a second device for testing and/or verification are provided herein. Such multichannel clip devices can include a spring-loaded clip having multiple electrical contacts for coupling with a contact portion of a first device and which are connected to a proximal connector through a flexible stimulation cable. The contacts can be included within a neurostimulation lead connector and the proximal connector adapted to couple with standard connectors on a clinician programmer, each contact being coupled to a corresponding contact of the proximal connector to define multiple separate channels. Such clip devices allow clinicians to test and/or verify multiple neurostimulation lead electrodes with a clinician programmers without requiring separate connection of each electrodes to a probe or test device and further allows for repeated sequencing or multi-plexing of neurostimulation leads during testing.

Multichannel clip device and methods of use

An integrated electromyography (EMG) and signal/stimulation generation clinician programmer may be coupled with an implantable temporary or permanent lead in a patient and at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. Generally, the integrated clinician programmer may comprise a portable housing, a signal/stimulation generator, and EMG signal processor, and a graphical user interface. The signal/stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The EMG signal processor may be disposed within the housing and configured to record a stimulation-induced EMG motor response for each test stimulation via the at least one EMG sensing electrode. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or a keyboard, mouse, or the like.

Integrated electromyographic clinician programmer for use with an implantable neurostimulator

Growing community of inventors

San Diego, CA, United States of America

Eric V Schmid